Swiss cannabis pilot projects — participants & timeline

Cumulative participants across all FOPH-approved pilot projects since 2023, broken down by city.

Key facts

  • Cumulative participants 2026: ≈ 4,200
  • Cities with active pilot: 5
  • First approval: Basel 2023

Key takeaways

  • Cumulative participation in FOPH-approved pilot trials grew from roughly 370 (Basel 2023) to about 4,200 in 2026 — more than a tenfold increase in three years.
  • Zurich (Züri Can) accounts for roughly 2,400 participants — well over half of all Swiss pilot slots.
  • Five cities run active studies in 2026; the newer projects (Bern, Lucerne, Geneva) run for five years, longer than the first cohorts.

Interpretation

Pilot trials are the only legal route to THC cannabis outside medicine — and their scale-up is the best leading indicator of eventual regulation. The shift from short feasibility studies (Basel, 2.5 years) to five-year cohorts shows that the federal government and cities are no longer testing safety but market models, price levels and prevention effects across a full cycle. Outside the five cities, access remains effectively closed: roughly 4,200 slots against some 220,000 regular users.

Limitations

  • Study teams count participants differently (enrolled vs active); we use the median published value.
  • Mid-year dropouts are not netted out of the cumulative figures.
  • For 2026 some cities have only published half-year communiqués, so annual values are estimates.

Data

CityStartParticipants 2026Duration (yrs)
Basel (Weed Care)2023-013802.5
Zürich (Züri Can)2023-0824003.5
Bern (SCRIPT)2024-094505
Luzern (Cannabis-Study)2025-023805
Genf (Cann-L)2025-055905

Methodology

Figures from official pilot communiqués and the FOPH overview. Cumulative participants at year-end. Where reports diverge we use the median published value.

Sources

Related data & articles

Parent

Related datasets

Matching knowledge hubs

Articles